Vaccine Therapy in Treating Patients With Breast Cancer
|ClinicalTrials.gov Identifier: NCT00524277|
Recruitment Status : Unknown
Verified November 2015 by COL George Peoples, MD, FACS, San Antonio Military Medical Center.
Recruitment status was: Active, not recruiting
First Posted : September 3, 2007
Last Update Posted : November 17, 2015
San Antonio Military Medical Center
Antigen Express, Inc.
Information provided by (Responsible Party):
COL George Peoples, MD, FACS, San Antonio Military Medical Center
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2017|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
May 1, 2018|
Publications of Results:
Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE. AE37: a novel T-cell-eliciting vaccine for breast cancer. Expert Opin Biol Ther. 2011 Nov;11(11):1543-50. doi: 10.1517/14712598.2011.616889. Epub 2011 Sep 6. Review.